Loading...
Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years
BACKGROUND: Bisphosphonate (BP) therapy has been associated with atypical femur fracture (AFF). However, the threshold of treatment duration leading to increased AFF risk is unclear. In a retrospective cohort of older women initiating BP, we compared the AFF risk associated with treatment for at lea...
Na minha lista:
| Udgivet i: | BMC Musculoskelet Disord |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7713036/ https://ncbi.nlm.nih.gov/pubmed/33272248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-020-03672-w |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|